首页> 美国卫生研究院文献>Interventional Neurology >Inadvertent Stent Retriever Detachment: A Multicenter Case Series and Review of Device Experience FDA Reports
【2h】

Inadvertent Stent Retriever Detachment: A Multicenter Case Series and Review of Device Experience FDA Reports

机译:无意间支架取出器:多中心案例系列和对设备经验的审查FDA报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mechanical thrombectomy using retrievable stents or stent retriever devices has become the mainstay of intra-arterial therapy for acute ischemic stroke. The recent publication of a series of positive trials supporting intra-arterial therapy as standard of care for the treatment of large vessel occlusion will likely further increase stent retriever use. Rarely, premature stent detachment during thrombectomy may be encountered. In our multicenter case series, we found a rate of detachment of less than 1% (n = 7/1,067), and all were first-generation Solitaire FR devices. A review of the US Food and Drug Administration database of device experience yielded 90 individual adverse reports of detachment. There were 82, 1 and 7 detachments of Solitaire FR (first generation), Solitaire FR2 (second generation) and Trevo devices, respectively. We conclude with a brief overview of the technical and procedural considerations which may be helpful in avoiding this rare complication.
机译:使用可回收支架或支架回收装置的机械血栓切除术已成为急性缺血性卒中的动脉内治疗的主要手段。最近一系列支持动脉内治疗作为治疗大血管阻塞的护理标准的阳性试验出版物可能会进一步增加支架回收器的使用。很少会在血栓切除术中发生支架过早脱落。在我们的多中心案例系列中,我们发现脱离率小于1%(n = 7 / 1,067),并且都是第一代纸牌FR设备。对美国食品和药物管理局的设备使用经验数据库进行的审查得出了90例独立的不良反应报告。 Solitaire FR(第一代),Solitaire FR2(第二代)和Trevo设备分别有82个,1个和7个支队。我们以技术和程序上的考虑因素的简要概述作为结束,这可能有助于避免这种罕见的并发症。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号